Published Date: 14 Mar 2023
The 2022-2023 flu season is on the edge of life which has been predicted for half of January and most of February.
Read Full NewsResidual Asthma Exacerbations on Biologics Vary by Mechanism
Newly announced Phase 4 THRIVE trial results showed most patients who previously had an inadequate response to a CGRP-targeting therapy improved with eptinezumab over 24 weeks.
Catch up on any of the neurology headlines you may have missed in September 2026, compiled into 1 place by the NeurologyLive® team.
Elizabeth Spencer, MD, discusses new data from 3 birth cohorts linking PFAS metabolites tied to maternal IBD to elevated calprotectin in children.
Jordan Axelrad, MD, MPH, discusses first-line IBD therapy selection, sequencing after failure, treat-to-target monitoring, and evaluating new agents
A gastroenterologist explains why IBD symptoms don't always signal a flare, the biomarkers used to confirm inflammation, and counseling patients through Crohn's disease.
ACG Guideline Sets 18 Preventive Care Recommendations for Cirrhosis
1.
When performed by skilled surgeons, robotic surgery for pancreatic tumors is safe and feasible.
2.
Taking Charge of Your Cancer Journey.
3.
Can the way we talk about cancer change how we interact with the disease?
4.
Chicken Broth Recall; Medicaid at Risk; Princess Kate Thanks Medical Staff
5.
Can Response-Adapted Surgery Improve Outcomes in HNSCC?
1.
Connected Cancer Survivorship Platforms: Transforming Post-Treatment Care Through Digital Integration
2.
Case-Based Learning: Persistent Neutropenia After Resolution of Infection
3.
Strategic Developments in Hematology and Quality Improvement
4.
Unlocking the Secrets of Blood Production: The Journey and Regulation of Hematopoietic Stem Cells
5.
Contemporary Advances in Hematology in the Digital Era
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
3.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
4.
A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months
5.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation